PATENT CLAIM ANALYSIS

Application Number: 16186879
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["514", "001400"]

Abstract:
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.

Claim (Index 18):
A method of treating a disease or medical condition by eliciting an agonist or antagonist effect from a melanocortin receptor according to  claim 14 , wherein said disease or condition is selected from the group consisting of:\n general inflammation, inflammatory bowel disease, brain inflammation, sepsis and septic shock; rheumatoid arthritis, gouty arthritis and multiple sclerosis; a metabolic disease or medical condition accompanied by weight gain, obesity, feeding disorders and Prader-Willi Syndrome; a metabolic disease or medical condition accompanied by weight loss, anorexia, bulimia, AIDS wasting, cachexia, cancer cachexia and wasting in frail elderly; skin cancer and cancer cachexia; endometriosis, uterine bleeding, sexual dysfunction, erectile dysfunction and decreased sexual response in females; organ transplant rejection, ischemia and reperfusion injury, wounding and spinal cord injury, and weight loss due to a medical procedure selected from the group consisting of chemotherapy, radiation therapy, temporary or permanent immobilization and dialysis; hemorrhagic shock, cardiogenic shock, hypovolemic shock, cardiovascular disorders and cardiac cachexia; acute respiratory distress syndrome, pulmonary fibrosis, chronic obstructive pulmonary disease and asthma; enhanced immune tolerance; allergies; psoriasis, skin pigmentation depletion, acne and keloid formation; anxiety, depression, memory dysfunction and neuropathic pain; and renal cachexia and natriuresis.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.46875
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12602010', '14024961', '13074565', '11988468', '15055873']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8979575392687857
- 35 USC 102 Novelty (BERT): 0.6317621038198354
- Combined Prediction Score: 0.8713379957238907
- Mean Citation Score: 625.486862
- Max Citation Score: 672.6033
- Similarity Product: 535.9900556326388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test